Glycated hemoglobin as a marker of dyslipidemia in type II Diabetic patients

Journal Title: International Journal of Medical and Dental Sciences - Year 2016, Vol 5, Issue 2

Abstract

Background: Diabetes is an important public health problem and leading cause of cardiovascular problems its early detection and good glycemic control can reduce the complications associated with the disease. Objective: This was a prospective study planned to evaluate the relationship of glycated haemoglobin (HbA1c) and lipid profile in type II diabetic Punjabi male population. Material and methods: A total of 200 diabetes type II patient ranging from age group of 30 to 70 years were included in the study after taking a preinformed written consent. The glycated haemoglobin (HbA1c) & lipid profile were performed on fully automated analyzers. The statistical analysis was done by using SPSS statistics and correlation among HbA1c and lipid profile of type II Diabetic patients was established. Results: The mean HbA1c was in the range of 7.54 ± 1.24%. There were 61% subjects with high total cholesterol (TC) levels and 96% were with raised LDL levels. The 68% of the subjects were having lower HDL level. HbA1c demonstrated significant positive relationship with total cholesterol, TC (r=0.995), triglyceride, TG (r=0.997), high density lipoprotein cholesterol, HDL-C (r=-0.940) and with low density lipoprotein cholesterol, LDL-C (r=0.993). Conclusion: The study concluded that HbA1c apart from acting as important diagnostic marker for glycemic control can also be used as a positive predictor of dyslipidemia in type 2 diabetics

Authors and Affiliations

Keywords

Related Articles

Tetracycline Knocking the Door, Once Again

This editorial highlights the hidden potentials of a long forgotten antibiotic tetracycline and urges the practioners to explore its clinical usefulness.

A Study of Prevalence of Aerobic Bacteria and Fungi in Sputum Specimens of Patients with Post Tubercular Bronchiectasis

Background: Patients with Post TB bronchiectasis colonize many aerobic bacteria and fungi and lead to an increase in exacerbations and decrease in quality of life. Objective: To study the prevalence of aerobic bacteria...

Posterior Reversible Encephalopathy Syndrome: A Rare Entity

Posterior reversible encephalopathy syndrome(PRES) is a proposed reversible cliniconeuroradiological entity characterized by headache, altered mental status, cortical blindness, seizures, focal neurological signs and a d...

Evidence of Costoclavicular Joint as A Synovial Joint

Introduction: The present study was conducted to note the osteological evidence of a synovial joint between clavicle and first rib in Indians. Material and Methods: The present study was conducted on 310 pairs of adult c...

Download PDF file
  • EP ID EP481032
  • DOI 10.19056/ijmdsjssmes/2016/v5i2/100600
  • Views 84
  • Downloads 0

How To Cite

(2016). Glycated hemoglobin as a marker of dyslipidemia in type II Diabetic patients. International Journal of Medical and Dental Sciences, 5(2), 1164-1170. https://www.europub.co.uk/articles/-A-481032